MyFinsight
Home
Compare
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$28,935K
EPS
-$0.98
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
Research and development
24,729
22,889
General and administrative
6,561
5,020
Total operating expenses
31,290
27,909
Loss from operations
-31,290
-27,909
Interest income
2,696
1,125
Interest expense
272
98
Other income (expense)
-69
13
Total other income
2,355
1,040
Net loss
-28,935
-26,869
Basic EPS
-0.98
-21.83
Diluted EPS
-0.98
-21.83
Basic Average Shares
29,650,660
1,230,698
Diluted Average Shares
29,650,660
1,230,698
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$2,696K
Net loss
-$28,935K
Total other income
$2,355K
Interest expense
$272K
Other income
(expense)
-$69K
Loss from operations
-$31,290K
Total operating
expenses
$31,290K
Research and development
$24,729K
General and
administrative
$6,561K
Buy us a coffee
Avalyn Pharma Inc. (AVLN)
Avalyn Pharma Inc. (AVLN)